Severe Atopic Dermatitis Remission With Dupilumab

Profiled is a case of a 35-year-old man with severe atopic dermatitis that was refractory to dupilumab monotherapy and responded to concomitant rescue tofacitinib therapy. No side effects were reported.

Reference: Peterson DM, Vesely MD. Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy. JAAD Case Rep. 2021 Feb 3;10:4-7. doi: 10.1016/j.jdcr.2021.01.020. PMID: 33728367; PMCID: PMC7935686.

Related Articles